ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy takes on advanced cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called N-3C01, given alone or with an immunotherapy, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the right dose, and see if the combination shrinks tumors. About 114 a…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Hefei Xinzhu Biological Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo therapy aims to outsmart drug-resistant lung cancer
Disease control Not yet recruitingThis study tests whether adding capivasertib to osimertinib can help people with a specific type of advanced lung cancer whose disease has worsened after initial treatment. About 53 adults with EGFR-mutant NSCLC and additional PIK3CA/AKT1/PTEN gene changes will receive the two dr…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Acupuncture with a jolt: could needles shield nerves from chemo?
Prevention Not yet recruitingThis study tests whether electroacupuncture (acupuncture with mild electrical pulses) combined with tiny thumbtack needles can prevent peripheral neuropathy—numbness, tingling, or pain—caused by chemotherapy in people with advanced cancer. The trial enrolls adults with stage IV b…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Affiliated Hospital of Qinghai University • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Fasting during immunotherapy: a new way to boost treatment?
Symptom relief Not yet recruitingThis study looks at whether intermittent fasting is safe and doable for people with advanced solid tumors who are starting immunotherapy. About 90 participants will be split into three groups: no fasting, eating only during an 8-hour window each day, or fasting every other day. R…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: West Virginia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Cancer Patients' samples to fuel Tomorrow's discoveries
Knowledge-focused Not yet recruitingThis study collects blood and tissue samples from 110 adults with advanced lung, head and neck, or mesothelioma cancer. The samples are stored in a biobank to help scientists study cancer genes and find better ways to predict treatment outcomes. Participants do not receive any ex…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Blood test may predict who benefits from lung cancer combo therapy
Knowledge-focused Not yet recruitingThis study aims to see if changes in certain immune cells in the blood can predict how well advanced lung cancer patients respond to a combination of chemotherapy and immunotherapy. About 80 adults with stage IIIB or IV non-small cell lung cancer will give blood samples before an…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Pain pills vs. cancer treatment: new study investigates opioid impact on immunotherapy
Knowledge-focused Not yet recruitingThis study looks at how opioid painkillers affect the success of immunotherapy in 100 people with advanced lung cancer who have moderate to severe pain. Researchers want to see if better pain control helps immunotherapy work better, and whether opioids themselves change the treat…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Sponsor: Hubei Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC